ARTICLE | Company News
V.I. Technologies blood products/substitutes news
May 17, 1999 7:00 AM UTC
VITX completed the recall of 37 lots of its PLAS+SD transfusion plasma containing moderate to high levels of parvovirus B19 DNA (see BioCentury, April 9). VITX said it has adopted a process to screen...